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ReviewGlossary
Circadian period: total time required for one complete daily cycle or oscillation.
Circadian phase: a distinct stage of an event that occurs or functions in
approximately 24 h intervals.
Circadian rhythm: ‘circa diem,’ or ‘about a day’ in Latin. Describes processes
that occur or function in approximately 24 h intervals.
Diurnal: active during the day and sleeping at night.
Enhancer box (E box): transcription factor binding site upstream of a gene in
promoter regions with a consensus DNA sequence of CANNTG.
Entrainment: a process of synchronizing circadian rhythm to a Zeitgeber.
Free-running conditions: the state of self-sustaining circadian rhythm in the
absence of Zeitgebers.
Phase-response curve: a graph showing the magnitude of circadian phase shift
depending on when the stimulus (e.g., light) is applied.
Subjective time: Segments of time corresponding to what the organism
perceives it to be; in other words, subjective day corresponds to the light phase
of the daily light cycle, whereas subjective night corresponds to the dark phase.
Wheel-running behavior: a method of estimating the circadian periodicity and
phase on an organismal level for rodents. A running-wheel is placed in a
recording cage and the number of revolutions approximates activity levels.
Because mice are nocturnal (active at night and sleeping during daytime),
wheel-running behavior usually occurs during the dark phase of the daily lightThe study of circadian rhythms is emerging as a fruitful
opportunity for understanding cellular mechanisms that
govern human physiology and behavior, fueled by evi-
dence directly linking sleep disorders to genetic muta-
tions affecting circadian molecular pathways. Familial
advanced sleep-phase disorder (FASPD) is the first rec-
ognized Mendelian circadian rhythm trait, and affected
individuals exhibit exceptionally early sleep–wake onset
due to altered post-translational regulation of period
homolog 2 (PER2). Behavioral and cellular circadian
rhythms are analogously affected because the circadian
period length of behavior is reduced in the absence of
environmental time cues, and cycle duration of the mo-
lecular clock is likewise shortened. In light of these
findings, we review the PER2 dynamics in the context
of circadian regulation to reveal the mechanism of sleep-
schedule modulation. Understanding PER2 regulation
and functionality may shed new light on how our genetic
composition can influence our sleep–wake behaviors.
Genetically hardwired configurations for sleep–wake
timing
‘I can’t help it – it’s genetic!’ remains a common exclama-
tion, but is our behavior truly etched in our DNA? Although
the current view implicates a combination of genetic and
environmental factors, an enduring question is how genes
alone can regulate innate behavior necessary for survival.
This is particularly relevant when considering the evolu-
tionarily advantages for organisms to anticipate and adapt
to environmental changes, such as those that fluctuate
approximately every 24 h, including the amount of sun-
light, temperature, nutritional availability, and the level of
predation. For example, organisms optimize certain beha-
viors, such as sleep, to occur at designated times. There-
fore, keeping track of time through a circadian rhythm (see
Glossary) ensures the execution of behaviors appropriate
for the environment, and this may ultimately enhance
evolutionary fitness [1].
Owing to the complexity of human behavior, pioneering
work on understanding the regulation of circadian rhythm
relied on model organisms. Konopka and Benzer identified
Drosophila melanogaster with various circadian timing
defects in locomotor activity, and these phenotypes were
attributed to mutant alleles of the same gene, appropri-
ately named period ( per) [2]. These studies demonstratedCorresponding author: Fu, Y-H. (ying-hui.fu@ucsf.edu)
Keywords: circadian rhythm; post-translational regulation; familial advanced sleep
phase disorder; phosphorylation; period homolog 2; casein kinase 1 delta.
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the floodgate for the study of analogous circadian genes in
mammalian model systems [3]. However, are human cir-
cadian behaviors also genetically ‘hard-wired’?
Although humans are by nature diurnal, there is a wide
spectrum of sleep–wake time preferences in the general
population, ranging from ‘morning larks’ to ‘night owls’ [4].
With the advent of high-throughput genotyping technolo-
gies, and the identification of conserved circadian genes,
mounting evidence now supports the role of genetics in
regulating sleep timing [5]. Nevertheless, the identifica-
tion of causative genes remains challenging due to complex
polygenic interactions, confounding environmental factors,
and a lack of human-relevant experimental models. To
overcome these difficulties, families with Mendelian sleep
traits were identified [6]. FASPD (previously known as
FASPS), the first recognized Mendelian circadian rhythm
phenotype, is autosomal dominant [7–10]. Individuals af-
fected by FASPD wake up well before sunrise and feel
compelled to sleep at around 7.30 pm [9]. This time-frame
is significantly advanced compared to the majority of the
population (Figure 1). Therapeutic attempts at delaying
sleep are usually unsuccessful, illustrating the ability of
genetics to ‘hardwire’ human circadian rhythmicity [11].
Three causative genetic variants have so far been identi-
fied ([12,13] and K.C. Brennan et al., unpublished). Thesecycle.
Zeitgeber: a source of information about the time of day, capable of entraining
circadian rhythm (e.g., light intensity).
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Figure 1. Clinical phase markers for familial advanced sleep-phase disorder (FASPD). FASPD-affected individuals (right) exhibit a marked advancement in phase markers of
overt rhythms related to sleep physiology as compared to the general population (left). Clock faces indicate the mean time of occurrence for each event, with lighter clock
faces indicating morning hours and darker clock faces indicating evening hours. Abbreviations: DLMO, dim-light melatonin onset; REM, rapid eye movement; Temp,
temperature. Data from [9].
Review Trends in Genetics December 2012, Vol. 28, No. 12mutations affect the phosphorylation of PER2, highlight-
ing the role of post-translational modifications in regulat-
ing human circadian rhythms. Here we review PER2
dynamics and functionality as a model for understanding
molecular mechanisms of circadian behavior. Because
there are nuanced differences between species (Box 1),
we will focus on evidence from mammalian model systems.
The ins and outs, highs and lows: intracellular dynamics
of PER2
Approximately 10–15% of gene transcripts oscillate in a
circadian manner, the identities of which vary according toBox 1. Are cellular mechanisms driving the circadian
rhythm conserved across species?
The ability to maintain a circadian rhythm is highly conserved, and
recent discoveries have unveiled analogous clock mechanisms in
species from diverse kingdoms. For most species, cellular circadian
rhythm is typified by core transcriptional–translational feedback loops
stabilized by interlocking loops, and the molecular substrates often
share homologous domains. However, there are notable exceptions –
for example, cyanobacteria and unicellular algae maintain circadian
rhythm by post-translational regulation without de novo synthesis of
clock components [75,76]. Remarkably, human red blood cells, which
do not have nuclei or perform transcription, undergo rhythmic 24 h
redox cycles [77]. It will not be surprising to find a future paradigm
shift towards non-transcriptional–translational mechanisms as more
‘exceptional’ cases continue to be discovered.
Nevertheless, there is a great deal of conservation, and mammalian
PER2 was initially discovered through a search for homologous cDNA
sequences to PER1, although it bears a greater resemblance to
Drosophila PER than its paralogs [59,61]. However, there are also
notable differences amongst species. For example, mammalian CRY
proteins replaced Drosophila TIM as a binding partner for PER1/2
[12,78]. In particular, even homologous proteins may function in a
different way in higher organisms. For instance, even though
transgenic mice carrying an FASPD mutation in CSNK1D recapitulate
the phenotype of human subjects, the opposite phenotype was
observed in Drosophila [10]. Therefore, it is important to keep in mind
the possibility of divergent mechanisms and exercise prudence when
comparing findings from different model organisms.cell type [12]. These oscillations are cell-intrinsic and
driven by a core set of transcription factors [12,13], con-
sisting of period homolog 1 (PER1) and PER2, crypto-
chrome 1 and 2 (CRY1 and CRY2), ARNTL (aryl
hydrocarbon receptor nuclear translocator-like; also
known as BMAL1), and clock homolog (CLOCK)
(Figure 2, inner circle). BMAL1 and CLOCK [or its paralog,
NPAS2 (neuronal PAS domain protein 2)] bind to E-box
promoter elements of PER1/2, CRY1/2, and other circa-
dian regulated genes in the nucleus and activate their
transcription. This leads to an increase in the levels of
PER1/2 and CRY1/2, which subsequently repress BMAL1/
CLOCK, leading to the termination of their own transcrip-
tion. Afterwards, PER1/2 and CRY1/2 are degraded
through proteosomal pathways, and the transcription of
PER1/2 and CRY1/2 is once again activated. This tran-
scriptional/translational negative feedback loop takes ap-
proximately 24 h to complete, and additional negative
feedback loops (also known as interlocking loops) of other
circadian regulators, such as RORA (RAR-related orphan
receptor A), NR1D1 (nuclear receptor subfamily 1, group D,
member 1; also known as REV-ERBA), BHLHE40/41 (ba-
sic helix-loop-helix family, members e40 and e41; also
known as DEC1/2), DBP (D site of albumin promoter-
binding protein), and NFIL3 (nuclear factor, interleukin
3 regulated; also known as E4BP4), act to either activate or
repress core clock components in a circadian manner [14].
Together, these components provide redundant and addi-
tional modes of regulation, reflected by the robustness and
the complexity of the molecular clock.
Although numerous molecular components coordinate to
drive circadian oscillations, precise rhythmicity of PER2
stands out as a crucial feature of the core clock [15,16].
The coordination of circadian output by PER2 is partially
mediated through interaction with nuclear receptors includ-
ing peroxisome PPARA (proliferator-activated receptor a)
and REV-ERBA [17]. Through a series of overexpression
experiments, in vitro and in vivo, it was shown in mice that599
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Figure 2. Regulation of PER2 intracellular dynamics plays a crucial role in core clock function. The core clock (inner circle, yellow) consists of a negative feedback loop
driven by the transcription, translation, repression, and degradation of the core clock components PER2 and CRY, which together drive the circadian rhythms of a cell. For
the sake of clarity, pathways pertaining to PER2 are emphasized in this figure, but interlocking negative feedback loops of other circadian genes such as CRY1/2 also
mediate the maintenance of robust circadian rhythmicity. The outer circle in orange illustrates molecular mechanisms pertaining to PER2 intracellular dynamics, which in
turn affect core clock events. Together, these processes take 24 h to complete. Abbreviations: Ac, acetyl group; B, BMAL1; BTRC, b-transducin repeat-containing E3
ubiquitin protein ligase; CLD, cytoplasmic localization domain; C, CLOCK; E, E-box promoter elements; HDAC1, histone deacetylase 1; KDM5A, lysine (K)-specific
demethylase 5A; MYBBP1A, MYB binding protein (P160) 1a; NES, nuclear export sequence; NLS, nuclear localization sequences; NONO, non-POU domain containing,
octamer-binding; PML, promyelocytic leukemia protein; PSF, polypyrimidine tract-binding protein-associated splicing factor; SIN3A, SIN3 transcription regulator homolog
A; SIRT1, Sirtuin 1; ub, ubiquitin; WDR5, WD repeat domain 5.
Review Trends in Genetics December 2012, Vol. 28, No. 12PER2 oscillation, rather than its absolute quantity, is cru-
cial for both cellular circadian oscillations and behavioral
rhythmicity [15]. To understand how this oscillation is
regulated we outline the progression of events responsible
for the production, nucleocytoplasmic shuttling, and subse-
quent repression and degradation of PER2. Together, the
timing of these events provides the cadence necessary for the
circadian expression of PER2, which in turn contributes to
the circadian rhythmicity of cellular processes and behavior.
From the beginning of time: transcriptional regulation of
PER2
The molecular core clock is defined as a negative feedback
mechanism wherein a protein is transcribed, translated,
and represses its own transcription over approximately
24 h. Because these processes occur continuously it would
be inaccurate to state definitively when the cycle starts, but
for the sake of clarity we begin by discussing PER2 tran-
scription (Figure 2, outer circle). Human PER2 resides on
Chr2q37.3, and mouse Per2 is found on Chr1qD. These600genes contain 23 exons, and their encoded proteins are
homologous to Drosophila PER [16]. Similarly to other core
clock genes, PER2 is regulated by a combination of enhanc-
er elements including E Boxes (recognized by BMAL1/
CLOCK) and D Boxes (recognized by DBP/E4BP4) [14].
These transcriptional binding elements work in tandem to
drive circadian oscillations of PER2 and other core clock
components. However, these transcription factors are
themselves regulated by PER2 and other core clock
components, which introduces further complexity to the
circadian transcriptional machinery due to implicated de-
pendencies between these circadian pathways. Moreover,
transcriptional regulation is intimately tied to epigenetic
mechanisms that activate and silence genes in a circadian
context, as discussed in the following section.
(Un)winding the clock: epigenetic regulation of circadian
rhythms
The pervasive role of epigenetics is now widely recognized
across biological fields of study, and circadian rhythmicity
Review Trends in Genetics December 2012, Vol. 28, No. 12is no exception. Early evidence demonstrated the rhythmic
acetylation of histone 3 and binding of RNA polymerase II
at the promoter regions of Per2, along with Per1 and Cry1,
suggesting that circadian rhythms are also epigenetically
regulated [18]. In agreement with these findings, recent
evidence reveals KDM1A [lysine (K)-specific demethylase
5A; also known as JARID1A] as a novel binding partner of
BMAL1/CLOCK. Reduction of KDM5A shortens the circa-
dian period of Per2 transcription in vitro, and this change is
attributed to the activation of Per2 transcription by
KDM5A through inhibition of HDAC1 (histone deacetylase
1) activity [19]. Hence, post-translational modifications of
histone proteins such as acetylation, methylation, SUMOy-
lation, and poly(ADP)-ribosylation may likewise affect the
transcription of core clock components such as Per2. Be-
cause core clock proteins are also directly post-translation-
ally modified, future research should strive to distinguish
between direct effects on protein function versus indirect
effects mediated by epigenetic mechanisms in regulating
circadian rhythms [20]. In addition, there may be links
between histone modifications and metabolic regulation of
the circadian clock, as reviewed by others [21].
Around the cell in one day: PER2 moves from the
nucleus to the cytoplasm and back
After PER2 is transcribed and translated, PER2 protein is
thought to accumulate in the cytoplasm. However, PER2 is
shuttled between the cytoplasm and the nucleus through a
number of regulatory mechanisms. First, PER2 contains a
putative cytoplasmic localization domain (CLD) with 43%
homology to Drosophila PER. However, this is not suffi-
cient for cytoplasmic retention of PER2, suggesting the
presence of other bona fide CLDs and/or the overriding
importance of other mechanisms in higher organisms [22].
Similarly, the presence of putative nuclear export
sequences (NES) flanking the CLD allows PER2 to be
transported into the cytoplasm via an exportin-mediated
nuclear export system [22–24]. These NES seem to be
redundant because the removal of all three is necessary
to retain PER2 in the nucleus [22]. Directing PER2 in the
opposite direction, nuclear localization sequences (NLS)
are sufficient for nuclear entry [25]. In addition, these
regulatory sequences act in concert with chaperone pro-
teins, including CRY1/2 in mammals, for PER2 transloca-
tion [12,26]. Interestingly, PER2 localization in the
nucleus is unimpaired in CRY1/2 knockout cells
[22,24,27], and recent evidence proposes that CRY1/2
may instead mitigate PER2 degradation in addition to
its collaborative function in repressing BMAL1/CLOCK
[22,28]. Taken together, these observations suggest addi-
tional chaperone proteins or other mechanisms for PER2
translocation, the identification of which will be an impor-
tant step toward understanding cellular circadian oscilla-
tions. One candidate is PML (promyelocytic leukemia
protein) because PER2 is found primarily in the cytoplasm
or around the nucleus in the absence of PML, and PML
knockout mice exhibit defective circadian wheel-running
behavior [26]. However, the effect of PML on BMAL1/
CLOCK transcription is paradoxical because it enhances,
rather than represses, Per2 transcription [26]. Therefore,
the exact mechanism of PML regulation of PER2 still needsto be investigated. Overall, nucleocytoplasmic shuttling of
PER2 appears to rely on regulatory mechanisms working
together to shift the equilibrium of transport in and out of
the nucleus. Further research is necessary to clarify how
PER2 translocation is integrated with other circadian
regulatory events.
Turning in for the night: PER2 repressor activity and
proteosomal degradation
As previously mentioned, PER1 and 2 repress their own
transcription by inhibiting BMAL1/CLOCK. This process
involves the recruitment of numerous protein complexes.
For example, NONO, an RNA- and DNA-binding protein
that may be involved in RNA export and splicing in addition
to transcriptional repression, binds to PER1/2, and its re-
duction results in dampened circadian rhythms in mamma-
lian cells [29]. Moreover, MYBBP1A, a transcription
cofactor with potential roles in histone regulation and the
recruitment of other transcription factors, is proposed to
complex with CRY1, which also binds to PER1/2 to co-
repress transcription [30]. Further emphasizing the code-
pendence between epigenetics and transcriptional regula-
tion, histone modifiers have been shown to participate in
PER-mediated transcriptional repression as well. SFPQ
(polypyrimidine tract-binding protein-associated splicing
factor; also known as PSF) and SIN3A, a scaffold for tran-
scription inhibitory complexes, interact with PER1 to drive
rhythmic recruitment of HDAC1 and subsequent deacetyla-
tion of histones 3 and 4 at the Per1 promoter, suggesting that
the same mechanism may be true for PER2, which also
complexes with PSF and SIN3A [31]. In addition, WDR5, a
member of a histone methytransferase complex, binds to
PER1/2, and knockdown of WDR5 reduces histone methyl-
ation at PER1-regulated promoters, implicating it in circa-
dian regulation [29]. However, reduction of WDR5 does not
affect the circadian period of luciferase driven by circadian
reporter genes [29], indicating additional compensatory
mechanisms, such as histone acetylation or other methods
of methylation, may be in place to ensure accurate circadian
periodicity. Together, this evidence demonstrates the com-
plexity and the resulting robustness of transcriptional neg-
ative feedback and the ubiquitous involvement of
epigenetics in circadian regulation.
After binding and repressing its own transcription,
PER2 is degraded through an ubiquitin-dependent proteo-
somal pathway. Protein degradation is crucial for main-
taining circadian period because proteasome inhibitors can
affect period length [32]. As mentioned above, PER2 deg-
radation may be prevented by binding to CRY1/2 [22]. The
stability of PER2 is also dependent on its acetylation,
which occurs once it binds to BMAL1/CLOCK [33]. Sirtuin
1 (SIRT1) then binds to BMAL1/CLOCK and deacetylates
PER2, promoting its degradation [34,35]. The degradation
process requires specific targeting via ubiquitylation.
FBXL3, a member of the SCF-containing ubiquitin ligase
complex, is important for CRY degradation, which in turn
regulates circadian period in vitro and in vivo [36–38].
Similarly, BTRC (b-transducin repeat-containing E3 ubi-
quitin protein ligase) may play a corresponding role in the
timely degradation of PER2 because deleting the BTRC-
interacting domain of PER2 results in its stabilization601
Review Trends in Genetics December 2012, Vol. 28, No. 12[39,40]. In addition to proteosomal targeting, inhibiting
nuclear export indirectly stabilizes PER2, suggesting that
degradation occurs after PER2 is exported back into the
cytoplasm [28]. Additional coupling mechanisms, such as
those linking protein translocation and degradation, may
be required to maintain circadian rhythm. Moreover,
PER2 intracellular dynamics are further regulated by
post-translational mechanisms, and they reveal the sub-
stantial influence of genetic mutations on circadian rhyth-
micity of cells and behavior, as discussed in the following
section.
Using human genetics to decode post-translational
circadian regulation
Although model systems have revealed the molecular sub-
strates of circadian rhythmicity, one of the most salient
questions is whether these findings apply to human circa-
dian behavior. Serendipitously, the first recognized human
Mendelian circadian rhythm genetic variant was a serine
to glycine mutation in PER2 at position 662 [9]. TransgenicFaster cycle
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g transcriptional repression or degradation of PER2. As revealed by studies using
ation of PER2 both affect the circadian period length of cells and wheel-running
identified priming kinase, resulting in enhanced transcriptional repression of PER2
r circadian period. The PER2-S662D mutation has the opposite effect, resulting in
xacerbate the effects of PER2-S662G on circadian period because transgenic
n through other putative phosphorylation sites and shortens circadian period even
longer circadian period, attributed to reduced PER2 degradation.
Review Trends in Genetics December 2012, Vol. 28, No. 12phospho-specific antibodies demonstrate that PER2-S662
phosphorylation stabilizes protein half-life [41].
Together, these results suggest the involvement of spe-
cific kinases and phosphatases in regulating circadian
pathways. Indeed, casein kinase 1 d (CSNK1D) is involved
in regulating transcription repressor activity and degra-
dation of PER2 through separate phosphorylation events.
Csnk1d heterozygosity counteracts the shortened circadi-
an period observed in PER2-S662G mice; the increase in
repressor activity is maintained by the PER2 mutation, but
there is less degradation of PER2, and this acts to correct
the shortened period [27]. Consistent with these findings,
pharmacological inhibition of CSNK1D lengthens the cir-
cadian period of locomotor activity, attributed to increased
PER2 nuclear retention [42]. Furthermore, additional
mutations underlying FASPD affect CSNK1D directly.
These mutations occur at amino acid 44 (from tyrosine
to alanine) or at amino acid 46 (unpublished), both of which
decrease CSNK1D enzymatic activity in vitro [13]. Sur-
prisingly, CSNK1D is not directly responsible for the
phosphorylation of PER2-S662 because in vitro kinase
assays reveal that S662 has to be phosphorylated by an
as yet unidentified priming kinase before the addition of
phosphate to downstream sites by CSNK1D [27]. Hence,
these experiments reveal the temporal complexity and site
specificity of phosphorylation cascades involved in core
clock regulation. Future research defining the stoichiome-
try of these events may provide insight into circadian
rhythmicity beyond transcriptional–translational feed-
back. For instance, recent findings on the dynamics of
casein kinase 1 e (CSNK1E) and protein phosphatase 1A
(PP1A) reinforce the idea that a delicate balance of phos-
phorylation kinetics is required for regulating circadian
periodicity [43,44].
In addition to phosphorylation, other forms of post-
translational modification may also regulate circadian
rhythms. Because other enzymes, such as GSK3B (glyco-
gen synthase kinase 3b) [45], PRKAA2 (protein kinase,
AMP-activated, a2 catalytic subunit; also known as
AMPK) [46,47], and an additional function of CLOCK as
an acetyltransferase [48–50], as well as PARP1 [poly (ADP-
ribose) polymerase 1] [51], are all implicated in post-trans-
lational circadian regulation, future discoveries of human
mutations affecting these genes may reveal mechanisms
directly relevant to human biology. In addition, small
chemical molecular activators and inhibitors are often able
to target circadian enzymatic pathways, and understand-
ing their underlying mechanistic effects will be valuable for
developing therapeutics aimed at sleep-phase disorders
[52,53]. In particular, drugs specifically aimed at correct-
ing circadian period length may prove to be useful for
treating FASPD. In the next section, we consider potential
mechanisms linking circadian period length and the tim-
ing of sleep–wake onset.
How can FASPD mutations affecting PER2 lead to
circadian phase advancement?
Although individuals with FASPD exhibit altered sleep-
timing patterns, it is important to note that sleep homeo-
stasis remains unaffected (the amount of sleep required),
distinguishing this syndrome from sleep disorders such asnarcolepsy [54] or the familial natural short-sleeper
(FNSS) phenotype [55]. In some cases, FASPD manifests
itself behaviorally through shortening the duration of free-
running activity period and advancing sleep and wake
onset [9]. Likewise, circadian pathways are also altered
in terms of both circadian period and phase as: transcript
levels of core and interlocking clock genes peak earlier for
PER2-S662G liver and fibroblast cells [27]. In addition,
temperature-synchronized fibroblasts exhibit an earlier
circadian phase when transfected with PER2 carrying
the FASPD mutation [28]. This evidence supports the
direct role of PER2-S662G in advancing the phase of
cellular circadian pathways. However, a longstanding
question that remains is how circadian phase and circadi-
an period are connected.
Whereas circadian period is correlated with the time
required for each cycle of the core clock, the molecular
mechanisms underlying circadian phase are not well un-
derstood. Because the human cellular and behavioral cir-
cadian period is not exactly 24 h, and varies between
individuals [9,56], it is thought that circadian phase is
adjusted by external cues to predict environmental fluc-
tuations. In addition, circadian behavior should ideally
adapt to gradual environmental variations such as season-
al changes in daylight availability, or acute changes such
as relocation to a different time zone. Light is the primary
source of time information, or Zeitgeber, and the molecular
circadian clock adjusts itself to light (a process known as
photoentrainment) to maintain an appropriate circadian
phase [1]. Indeed, some blind individuals exhibit a consis-
tent delay in sleep/wake onset relative to the previous day,
similar to that observed in humans under experimental
free-running conditions dominated by constant darkness
[11]. Recent studies have illuminated cellular mechanisms
underlying our ability to photoentrain, with focus placed on
the role of intrinsically photosensitive melanopsin-expres-
sing retinal ganglion cells (ipRGCs) in transmitting light
levels to the suprachiasmatic nucleus of the hypothalamus
(SCN) [57,58]. Interestingly, it appears that the timing of
light administration differentially affects Per2; notably,
expression in the SCN is upregulated by light in early
subjective night, but not in late subjective night [59–62]. In
addition, light pulses administered in artificial ‘dawn’
versus ‘dusk’ conditions differentially affect Per2 mRNA
levels, with the latter resulting in increased amplitude and
duration of transcript expression [63]. Similarly, phase-
response curves to light for humans traditionally demon-
strate that morning light tends to phase advance, whereas
evening light tends to phase delay, with variations be-
tween individuals for the timing of maximum light sensi-
tivity [11]. Together, these findings point to distinct effects
of light on PER2 expression, depending on when it is
administered in relation to subjective time. Although these
results are only correlative, and PER2 expression is prob-
ably one of many changes imposed on the circadian molec-
ular machinery in response to light, it is an important first
step toward deciphering the relationships between en-
trainment cues and the molecular clock. Understanding
the molecular underpinnings of these variations may re-
veal fresh insight into circadian-rhythm sleep disorders
(CRSDs). Supporting this notion, successful phototherapy603
Review Trends in Genetics December 2012, Vol. 28, No. 12for remediating CRSDs such as FASPD may need to take
into consideration the differential effects of light at differ-
ent times of day for maximum efficacy [11].
Concluding remarks
Akin to how one would disassemble a mechanical timepiece
to study its inner workings, disrupting and restoring the
molecular clock allows us to infer mechanisms driving
circadian behavior. Recent work addressing the intracel-
lular dynamics of PER2 based on human mutations has
revealed a prominent role for post-translational regulation
in driving cellular circadian oscillations. These results also
underscore the importance of studying the relationship
between circadian period and phase in the context of
PER2 to gain further information about its myriad roles.
The identification of additional genes and alleles for
FASPD and other sleep disorders may reveal additional
regulatory mechanisms for PER2 and novel human-rele-
vant components of the circadian pathway.
Aside from FASPD, PER2 is also implicated in cancer
[64,65], food anticipatory behavior [66], metabolism
[67,68], immune responses [69], and alcohol intake [70].
How can the dysregulation of PER2 ultimately lead to
distinct physiological and behavioral outcomes? One pos-
sibility is that some aspects of PER2 regulation and func-
tion are cell type-specific. Indeed, knocking out Bmal1 in
the liver does not affect Per2 expression, whereas the
absence of Bmal1 in other tissues significantly reduces
Per2 at normal peak time [71]. Future studies using cell
type-specific activation of PER2 human mutations may
discern the cellular origins of behavioral rhythmicity.
Recent findings have identified PER2 oscillation in other
anatomical regions besides the SCN, and understanding
these connections may expand our knowledge of the neural
circuitry for determining the timing of behavior [72].
Moreover, aside from neurons, PER2 is also expressed
in glia, which may also contribute to circadian behavioral
timing in the nervous system [73]. Finally, although brain-
specific PER2 oscillation is sufficient for rhythmic wheel-
running in mice, one cannot discount the possibility of
feedback mechanisms from peripheral organs and other
parts of the nervous system for mediating circadian out-
comes [74].
As evidenced by the intricacies of PER2 intracellular
dynamics, and the importance of post-translational circa-
dian regulation, it becomes clear that the ‘core’ transcrip-
tional-translational loop may be only one facet of the
biological clock. Therefore, it is important to keep an open
mind and consider mechanisms beyond the canonical cir-
cadian pathway. As Sir Francis Bacon once said, ‘truth is
the daughter of time, not of authority.’ Perhaps the rigor-
ous study of biological time may also lead us closer to the
truth behind genetic regulation of innate behavior.
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